+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Resveratrol Market by Product Type, Form, Application: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • PDF Icon

    Report

  • 285 Pages
  • October 2021
  • Region: Global
  • Allied Market Research
  • ID: 5521607
Description Jump to:
The global resveratrol market was valued at $71,880.4 thousand in 2020, and is projected to reach $131,031.4 thousand by 2030, registering a CAGR of 6.2% from 2021 to 2030.



Resveratrol is one of the category of plant polyphenols which has antioxidant and anti-inflammatory properties. Resveratrol is a type of natural polyphenol usually found in several plants. The use of resveratrol in the pharmaceutical industry is rising due its potential therapeutic use. Moreover, Resveratrol has been promoted to have many health benefits including treating and preventing cardiovascular disease, protecting against clots, lowering cholesterol, and other which in turn has propelled the demand for resveratrol in the pharmaceuticals industry. This, in turn has bolstered the growth of the overall resveratrol market in terms of value sales.

Resveratrol is largely used in the nutraceuticals industry. This is attributed to the high consumption and demand for nutraceutical supplements which in turn is driving the growth of the market. In addition, Flavonoid in the pharmaceutical industry is used for its antioxidant properties. This in turn is also propelling the growth of the market. However, low penetration of resveratrol in developing countries is restricting the growth of the market. Nevertheless, Upsurge in the usage of resveratrol in the Food & beverages and animal feed Industry as an ingredient is likely to offer immense opportunities for the growth of the market during the forecast period.

The global resveratrol market is segmented are categorized into product type, form application and region. By product type, it is classified into natural resveratrol and synthetic resveratrol. By form, the market is bifurcated into powder and liquid. By application, it is divided into pharmaceuticals, nutraceuticals, cosmetics and others. Region wise, the market is analyzed across North America (the U.S., Canada and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia and rest of Europe), Asia-Pacific (China, Japan, India, Australia & New Zealand, South Korea, ASEAN and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, Argentina and Rest of LAMEA).

Some of the major players in the global flavonoid industry analyzed in this report include botaniex inc., chongqing kerui nanhai pharmaceutical co., ltd., evolva, foodchem international corporation, good-yg-biotech, haihang industry co., ltd , hubei sanxin biotechnology co., limited, honghao herbs, sichuan xieli pharmaceutical co. ltd and xi'an chen lang biological technology co., ltd.

Key Benefits for Stakeholders

  • This report provides a quantitative analysis of the current resveratrol market trends, estimations, and dynamics of the global market from 2020 to 2030 to identify the prevailing market opportunities.
  • The key countries in all the major regions are mapped based on their market share.
  • Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the market segmentation assists in determining the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global industry. Market player positioning segment facilitates benchmarking and provides a clear understanding of the present position of market players.
  • The report includes the analysis of the regional as well as global market, key players, market segments, end use, and growth strategies.

KEY MARKET SEGMENTS


By Product type

  • Natural resveratrol
  • Synthetic resveratrol

By Form

  • Powder
  • Liquid

By Application

  • Dietary Supplements
  • Pharmaceuticals
  • Cosmetics
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • South Korea
  • ASEAN
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Argentina
  • Rest of LAMEA

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. COVID-19 impact on resveratrol market
3.6. Top Impacting Factor
3.7. Parent Market Analysis
3.8. Market dynamics
3.8.1. Drivers
3.8.1.1. Rising usage of resveratrol in pharmaceutical industry
3.8.1.1. Rising adoption of resveratrol in nutraceuticals industry
3.8.1.2. Growing usage of resveratrol in cosmetic industry
3.8.2. Restraints
3.8.2.1. Low penetration in developing regions
3.8.2.2. Potential threat of substitution
3.8.3. Opportunities
3.8.3.1. Upsurge in the usage of resveratrol in the Food & beverages Industry
3.8.3.2. Rapid growth of online retail platform
CHAPTER 4: RESVERATROL MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Natural Resveratrol
4.2.1. Key market trends, growth factors, and opportunities.
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Synthetic Resveratrol
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
CHAPTER 5: RESVERATROL MARKET, BY FORM
5.1. Overview
5.1.1. Market size and forecast
5.3. Powder
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast
5.3.3. Market analysis, by country
5.4. Liquid
5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast
5.4.3. Market analysis, by country
CHAPTER 6: RESVERATROL MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Nutraceuticals
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast
6.2.3. Market analysis, by country
6.3. Pharmaceuticals
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast
6.3.3. Market analysis, by country
6.4. Cosmetics
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast
6.4.3. Market analysis, by country
6.5. Others
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast
6.5.3. Market analysis, by country
CHAPTER 7: RESVERATROL MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast, by region
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by product type
7.2.3. Market size and forecast, by form
7.2.4. Market size and forecast, by application
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by product type
7.2.5.1.2. Market size and forecast, by form
7.2.5.1.3. Market size and forecast, by application
7.2.5.2. Mexico
7.2.5.2.1. Market size and forecast, by product type
7.2.5.2.2. Market size and forecast, by form
7.2.5.2.3. Market size and forecast, by application
7.2.5.3. Canada
7.2.5.3.1. Market size and forecast, by product type
7.2.5.3.2. Market size and forecast, by form
7.2.5.3.3. Market size and forecast, by application
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by product type
7.3.3. Market size and forecast, by form
7.3.4. Market size and forecast, by application
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by product type
7.3.5.1.2. Market size and forecast, by form
7.3.5.1.3. Market size and forecast, by application
7.3.5.2. UK
7.3.5.2.1. Market size and forecast, by product type
7.3.5.2.2. Market size and forecast, by form
7.3.5.2.3. Market size and forecast, by application
7.3.5.3. France
7.3.5.3.1. Market size and forecast, by product type
7.3.5.3.2. Market size and forecast, by form
7.3.5.3.3. Market size and forecast, by application
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by product type
7.3.5.4.2. Market size and forecast, by form
7.3.5.4.3. Market size and forecast, by application
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by product type
7.3.5.5.2. Market size and forecast, by form
7.3.5.5.3. Market size and forecast, by application
7.3.5.6. Russia
7.3.5.6.1. Market size and forecast, by product type
7.3.5.6.2. Market size and forecast, by form
7.3.5.6.3. Market size and forecast, by application
7.3.5.7. Rest of Europe
7.3.5.7.1. Market size and forecast, by product type
7.3.5.7.2. Market size and forecast, by form
7.3.5.7.3. Market size and forecast, by application
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by product type
7.4.3. Market size and forecast, by form
7.4.4. Market size and forecast, by application
7.4.5. Market size and forecast, by country
7.4.5.1. India
7.4.5.1.1. Market size and forecast, by product type
7.4.5.1.2. Market size and forecast, by form
7.4.5.1.3. Market size and forecast, by application
7.4.5.2. Japan
7.4.5.2.1. Market size and forecast, by product type
7.4.5.2.2. Market size and forecast, by form
7.4.5.2.3. Market size and forecast, by application
7.4.5.3. China
7.4.5.3.1. Market size and forecast, by product type
7.4.5.3.2. Market size and forecast, by form
7.4.5.3.3. Market size and forecast, by application
7.4.5.4. Australia & New Zealand
7.4.5.4.1. Market size and forecast, by product type
7.4.5.4.2. Market size and forecast, by form
7.4.5.4.3. Market size and forecast, by application
7.4.5.5. ASEAN
7.4.5.5.1. Market size and forecast, by product type
7.4.5.5.2. Market size and forecast, by form
7.4.5.5.3. Market size and forecast, by application
7.4.5.6. South Korea
7.4.5.6.1. Market size and forecast, by product type
7.4.5.6.2. Market size and forecast, by form
7.4.5.6.3. Market size and forecast, by application
7.4.5.7. Rest of Asia-Pacific
7.4.5.7.1. Market size and forecast, by product type
7.4.5.7.2. Market size and forecast, by form
7.4.5.7.3. Market size and forecast, by application
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by product type
7.5.3. Market size and forecast, by form
7.5.4. Market size and forecast, by application
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by product type
7.5.5.1.2. Market size and forecast, by form
7.5.5.1.3. Market size and forecast, by application
7.5.5.2. Saudi Arabia
7.5.5.2.1. Market size and forecast, by product type
7.5.5.2.2. Market size and forecast, by form
7.5.5.2.3. Market size and forecast, by application
7.5.5.3. South Africa
7.5.5.3.1. Market size and forecast, by product type
7.5.5.3.2. Market size and forecast, by form
7.5.5.3.3. Market size and forecast, by application
7.5.5.4. Argentina
7.5.5.4.1. Market size and forecast, by product type
7.5.5.4.2. Market size and forecast, by form
7.5.5.4.3. Market size and forecast, by application
7.5.5.5. Rest of LAMEA
7.5.5.5.1. Market size and forecast, by product type
7.5.5.5.2. Market size and forecast, by form
7.5.5.5.3. Market size and forecast, by application
CHAPTER 8: COMPETITION LANDSCAPE
9.1. Top player positioning
9.2. Competitive dashboard
9.3. Competitive heat map
9.4. Key developments
9.4.1. Acquisition
9.4.2. Business Expansion
9.4.3. Product Launch
CHAPTER 10: COMPANY PROFILES
10.1. BOTANIEX INC.
10.1.1. Company overview
10.1.2. Key Executives
10.1.3. Company snapshot
10.1.4. Product portfolio
10.2. CHONGQING KERUI NANHAI PHARMACEUTICAL CO., LTD.
10.2.1. Company overview
10.2.2. Company snapshot
10.2.3. Product portfolio
10.3. EVOLVA
10.3.1. Company overview
10.3.2. Key Executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.3.6. R&D Expenditure
10.3.7. Business performance
10.3.8. Key strategic moves and developments
10.4. FOODCHEM INTERNATIONAL CORPORATION
10.4.1. Company overview
10.4.2. Company snapshot
10.4.3. Product portfolio
10.5. GOOD-YG-BIOTECH
10.5.1. Company overview
10.5.2. Company snapshot
10.5.3. Operating business segments
10.5.4. Product portfolio
10.6. HAIHANG INDUSTRY CO., LTD
10.6.1. Company overview
10.6.2. Key Executives
10.6.3. Company snapshot
10.6.4. Product portfolio
10.7. HUBEI SANXIN BIOTECHNOLOGY CO., LIMITED
10.7.1. Company overview
10.7.2. Company snapshot
10.7.3. Product portfolio
10.8. HONGHAO HERB
10.8.1. Company overview
10.8.2. Company snapshot
10.8.3. Product portfolio
10.9. SICHUAN XIELI PHARMACEUTICAL CO. LTD
10.9.1. Company overview
10.9.2. Company snapshot
10.9.3. Product portfolio
10.10. XI'AN CHEN LANG BIOLOGICAL TECHNOLOGY CO., LTD
10.10.1. Company overview
10.10.2. Company snapshot
10.10.3. Operating business segments
10.10.4. Product portfolio
List of Tables
TABLE 01. RESVERATROL MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 02. NATURAL RESVERATROL MARKET REVENUE, BY REGION, 2020-2030 ($ THOUSAND)
TABLE 03. SYNTHETIC RESVERATROL MARKET REVENUE, BY REGION, 2020-2030 ($ THOUSAND)
TABLE 04. RESVERATROL MARKET REVENUE, BY FORM 2020-2030 ($ THOUSAND)
TABLE 05. RESVERATROL MARKET REVENUE FROM POWDER, BY REGION, 2020-2030 ($ THOUSAND)
TABLE 06. RESVERATROL MARKET REVENUE FROM LIQUID, BY REGION, 2020-2030 ($ THOUSAND)
TABLE 07. RESVERATROL MARKET REVENUE, BY APPLICATION 2020-2030($ THOUSAND)
TABLE 08. RESVERATROL MARKET REVENUE FOR NUTRACEUTICALS, BY REGION, 2020-2030($ THOUSAND)
TABLE 09. GLOBAL PHARMACEUTICALS RESVERATROL MARKET REVENUE, BY REGION, 2020-2030($ THOUSAND)
TABLE 10. RESVERATROL MARKET REVENUE FROM COSMETICS, BY REGION, 2020-2030($ THOUSAND)
TABLE 11. RESVERATROL MARKET REVENUE FROM OTHERS, BY REGION, 2020-2030($ THOUSAND)
TABLE 12. RESVERATROL MARKET REVENUE, BY REGION, 2020-2030 ($ THOUSAND)
TABLE 13. NORTH AMERICA RESVERATROL MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 14. NORTH AMERICA RESVERATROL MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 15. NORTH AMERICA RESVERATROL MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 16. NORTH AMERICA RESVERATROL MARKET REVENUE, BY COUNTRY, 2020-2030 ($ THOUSAND)
TABLE 17. U.S. RESVERATROL MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 18. U.S. RESVERATROL MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 19. U.S RESVERATROL MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 20. MEXICO RESVERATROL MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 21. MEXICO RESVERATROL MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 22. MEXICO RESVERATROL MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 23. CANADA RESVERATROL MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 24. CANADA RESVERATROL MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 25. CANADA RESVERATROL MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 26. EUROPE RESVERATROL MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 27. EUROPE RESVERATROL MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 28. EUROPE RESVERATROL MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 29. EUROPE RESVERATROL MARKET REVENUE, BY COUNTRY, 2020-2030 ($ THOUSAND)
TABLE 30. GERMANY RESVERATROL MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 31. GERMANY RESVERATROL MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 32. GERMANY RESVERATROL MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 33. UK RESVERATROL MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 34. UK RESVERATROL MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 35. UK RESVERATROL MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 36. FRANCE RESVERATROL MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 37. FRANCE RESVERATROL MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 38. FRANCE RESVERATROL MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 39. ITALY RESVERATROL MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 40. ITALY RESVERATROL MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 41. ITALY RESVERATROL MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 42. SPAIN RESVERATROL MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 43. SPAIN RESVERATROL MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 44. SPAIN RESVERATROL MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 45. RUSSIA RESVERATROL MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 46. RUSSIA RESVERATROL MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 47. RUSSIA RESVERATROL MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 48. REST OF EUROPE RESVERATROL MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 49. REST OF EUROPE RESVERATROL MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 50. REST OF EUROPE RESVERATROL MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 51. ASIA-PACIFIC RESVERATROL MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 52. ASIA-PACIFIC RESVERATROL MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 53. ASIA-PACIFIC RESVERATROL MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 54. ASIA-PACIFIC RESVERATROL MARKET REVENUE, BY COUNTRY, 2020-2030 ($ THOUSAND)
TABLE 55. INDIA RESVERATROL MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 56. INDIA RESVERATROL MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 57. INDIA RESVERATROL MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 58. JAPAN RESVERATROL MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 59. JAPAN RESVERATROL MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 60. JAPAN RESVERATROL MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 61. CHINA RESVERATROL MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 62. CHINA RESVERATROL MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 63. CHINA RESVERATROL MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 64. AUSTRALIA & NEW ZEALAND RESVERATROL MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 65. AUSTRALIA & NEW ZEALAND RESVERATROL MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 66. AUSTRALIA & NEW ZEALAND RESVERATROL MARKET REVENUE, BY APPLICATION, 2020-2030 ($ THOUSAND)
TABLE 67. ASEAN RESVERATROL MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 68. ASEAN RESVERATROL MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 69. ASEAN RESVERATROL MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 70. SOUTH KOREA RESVERATROL MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 71. SOUTH KOREA RESVERATROL MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 72. SOUTH KOREA RESVERATROL MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 73. REST OF ASIA-PACIFIC RESVERATROL MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 74. REST OF ASIA-PACIFIC RESVERATROL MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 75. REST OF ASIA-PACIFIC RESVERATROL MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 76. LAMEA RESVERATROL MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 77. LAMEA RESVERATROL MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 78. LAMEA RESVERATROL MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 79. LAMEA RESVERATROL MARKET REVENUE, BY COUNTRY, 2020-2030 ($ THOUSAND)
TABLE 80. BRAZIL RESVERATROL MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 81. BRAZIL RESVERATROL MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 82. BRAZIL RESVERATROL MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 83. SAUDI ARABIA RESVERATROL MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 84. SAUDI ARABIA RESVERATROL MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 85. SAUDI ARABIA RESVERATROL MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 86. SOUTH AFRICA RESVERATROL MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 87. SOUTH AFRICA RESVERATROL MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 88. SOUTH AFRICA RESVERATROL MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 89. ARGENTINA RESVERATROL MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 90. ARGENTINA RESVERATROL MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 91. ARGENTINA RESVERATROL MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 92. REST OF LAMEA RESVERATROL MARKET REVENUE, BY PRODUCT TYPE, 2020-2030 ($ THOUSAND)
TABLE 93. REST OF LAMEA RESVERATROL MARKET REVENUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 94. REST OF LAMEA RESVERATROL MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 95. BOTANIEX INC: KEY EXECUTIVES
TABLE 96. BOTANIEX INC: COMPANY SNAPSHOT
TABLE 97. BOTANIEX INC: PRODUCT PORTFOLIO
TABLE 98. CHONGQING KERUI NANHAI PHARMACEUTICAL CO., LTD: COMPANY SNAPSHOT
TABLE 99. CHONGQING KERUI NANHAI PHARMACEUTICAL CO., LTD: PRODUCT PORTFOLIO
TABLE 100. EVOLVA: KEY EXECUTIVES
TABLE 101. EVOLVA: COMPANY SNAPSHOT
TABLE 102. EVOLVA: OPERATING SEGMENTS
TABLE 103. EVOLVA: PRODUCT PORTFOLIO
TABLE 104. EVOLVA: R&D EXPENDITURE, 2017-2019 ($THOUSNAD)
TABLE 105. EVOLVA: NET SALES, 2018-2020 ($THOUSAND)
TABLE 106. FOODCHEM INTERNATIONAL CORPORATION: COMPANY SNAPSHOT
TABLE 107. FOODCHEM INTERNATIONAL CORPORATION: PRODUCT PORTFOLIO
TABLE 108. YOUGU BIOTECH: COMPANY SNAPSHOT
TABLE 109. YOUGU BIOTECH: OPERATING SEGMENTS
TABLE 110. YOUGU BIOTECH: PRODUCT PORTFOLIO
TABLE 111. HAIHANG INDUSTRY CO., LTD: KEY EXECUTIVES
TABLE 112. HAIHANG INDUSTRY CO., LTD: COMPANY SNAPSHOT
TABLE 113. HAIHANG INDUSTRY CO., LTD: PRODUCT PORTFOLIO
TABLE 114. HUBEI SANXIN BIOTECHNOLOGY CO., LIMITED: COMPANY SNAPSHOT
TABLE 115. HUBEI SANXIN BIOTECHNOLOGY CO., LIMITED: PRODUCT PORTFOLIO
TABLE 116. HONGHAO HERB: COMPANY SNAPSHOT
TABLE 117. HONGHAO HERB: PRODUCT PORTFOLIO
TABLE 118. XIELI PHARM: COMPANY SNAPSHOT
TABLE 119. XIELI PHARM: PRODUCT PORTFOLIO
TABLE 120. XI'AN CHEN LANG BIOLOGICAL TECHNOLOGY CO., LTD: COMPANY SNAPSHOT
TABLE 121. XI'AN CHEN LANG BIOLOGICAL TECHNOLOGY CO., LTD: OPERATING SEGMENTS
TABLE 122. XI'AN CHEN LANG BIOLOGICAL TECHNOLOGY CO., LTD: PRODUCT PORTFOLIO
List of Figures
FIGURE 01. RESVERATROL MARKET: SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 04. HIGH BARGAINING POWER OF BUYER
FIGURE 05. MODERATE THREAT OF SUBSTITUTION
FIGURE 06. HIGH THREAT OF NEW ENTRANTS
FIGURE 07. MODERATE INTENSITY OF COMPETITIVE RIVALRY
FIGURE 08. RESVERATROL MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 09. RESVERATROL MARKET: TOP IMPACTING FACTOR
FIGURE 10. RESVERATROL MARKET: PARENT MARKET ANALYSIS
FIGURE 11. RESVERATROL MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 12. RESVERATROL MARKET, BY PRODUCT TYPE, 2020 (%)
FIGURE 13. COMPARATIVE MARKET SHARE ANALYSIS OF NATURAL RESVERATROL MARKET, BY COUNTRY,2020 AND 2030 (%)
FIGURE 14. COMPARATIVE MARKET SHARE ANALYSIS OF SYNTHETIC RESVERATROL MARKET, BY COUNTRY 2020 AND 2030 (%)
FIGURE 15. RESVERATROL MARKET, BY FORM, 2020 (%)
FIGURE 16. COMPARATIVE MARKET SHARE ANALYSIS OF RESVERATROL MARKET FROM LIQUID, BY COUNTRY ,2020 AND 2030 (%)
FIGURE 17. COMPARATIVE MARKET SHARE ANALYSIS OF RESVERATROL MARKET FROM LIQUID, BY COUNTRY ,2020 AND 2030 (%)
FIGURE 18. RESVERATROL MARKET, BY APPLICATION, 2020 (%)
FIGURE 19. COMPARATIVE MARKET SHARE ANALYSIS OF RESVERATROL MARKET REVENUE FOR NUTRACEUTICALS, BY COUNTRY, 2020 AND 2030(%)
FIGURE 20. COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF RESVERATROL MARKET FROM PHARMACEUTICALS, BY COUNTRY, 2020 AND 2030(%)
FIGURE 21. COMPARATIVE L MARKET SHARE ANALYSIS OF RESVERATROL MARKET REVENUE FROM COSMETICS, BY COUNT-RY, 2020 AND 2030(%)
FIGURE 22. COMPARATIVE MARKET SHARE ANALYSIS OF RESVERATROL MARKET REVENUE FROM OTHERS, BY COUNTRY, 2020 AND 2030(%)
FIGURE 23. RESVERATROL MARKET, BY REGION, 2020 (%)
FIGURE 24. U.S. RESVERATROL MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 25. MEXICO RESVERATROL MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 26. CANADA RESVERATROL MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 27. GERMANY RESVERATROL MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 28. UK RESVERATROL MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 29. FRANCE RESVERATROL MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 30. ITALY RESVERATROL MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 31. SPAIN RESVERATROL MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 32. RUSSIA RESVERATROL MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 33. REST OF EUROPE RESVERATROL MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 34. INDIA RESVERATROL MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 35. JAPAN RESVERATROL MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 36. CHINA RESVERATROL MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 37. AUSTRALIA & NEW ZEALAND RESVERATROL MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 38. ASEAN RESVERATROL MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 39. SOUTH KOREA RESVERATROL MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 40. REST OF ASIA-PACIFIC RESVERATROL MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 41. BRAZIL RESVERATROL MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 42. SAUDI ARABIA RESVERATROL MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 43. SOUTH AFRICA RESVERATROL MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 44. ARGENTINA RESVERATROL MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 45. REST OF LAMEA RESVERATROL MARKET REVENUE, 2020-2030 ($ THOUSAND)
FIGURE 46. COMPETITIVE DASHBOARD OF TOP 10 KEY PLAYERS
FIGURE 47. COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 48. EVOLVA: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 49. EVOLVA: NET SALES, 2018-2020 ($MILLION)
FIGURE 50. EVOLVA: REVENUE SHARE BY REGION, 2020 (%)

Companies Mentioned

  • botaniex inc.
  • chongqing kerui nanhai pharmaceutical co. LTD.
  • evolva
  • foodchem international corporation
  • good-yg-biotech
  • haihang industry co. LTD.
  • hubei sanxin biotechnology co.
  • limited
  • honghao herbs
  • sichuan xieli pharmaceutical co. ltd
  • xi'an chen lang biological technology co. LTD

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages285
PublishedOctober 2021
Forecast Period2020 - 2030
Estimated Market Value ( USD ) in 2020 $ 71880.4 thousand
Forecasted Market Value ( USD ) by 2030 $ 131031.4 thousand
Compound Annual Growth Rate6.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Resveratrol Market: Industry Size, Share, Competition, Trends, Growth Opportunities and Forecasts by Region - Insights and Outlook by Product, 2024 to 2031 - Product Image

Resveratrol Market: Industry Size, Share, Competition, Trends, Growth Opportunities and Forecasts by Region - Insights and Outlook by Product, 2024 to 2031

  • Report
  • 156 Pages
  • Global
From
Resveratrol (CAS 501-36-0) Global Market Research Report 2024 - Product Image

Resveratrol (CAS 501-36-0) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Phycocyanin Market by Form, Grade, Application, Geography - Global Forecast to 2030 - Product Image

Phycocyanin Market by Form, Grade, Application, Geography - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
Lignin Market Forecast to 2028 - Global Analysis by Type, by Form, by Application - Product Image

Lignin Market Forecast to 2028 - Global Analysis by Type, by Form, by Application

  • Report
  • 191 Pages
  • Global
From
Glycerin - Global Strategic Business Report - Product Image

Glycerin - Global Strategic Business Report

  • Report
  • 588 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.